Working primarily with private individuals, start-ups, SMEs and Universities, Rob has experience working across a wide range of technical areas and with clients from a variety of backgrounds. He is responsible for drafting and prosecuting UK, European and International patent applications and has particular experience in handling patent in the areas of medical devices, robotic vehicles, fluid pumping and control systems and construction technologies.
Rob is always interested to learn about new ideas, and particularly enjoys discussing how these can be developed into a commercial offering that will differentiate these new products and services from those that already exist.
Rob believes understanding what each client's business aims are and how their technology impacts this, is core to providing an IP strategy that is sustainable for the business in the long term.
Clinical Medicine Research
Intellectual Property Law
March 10th 2022
Rob is a tutor for trainees preparing to sit the Advanced IP Law and Practice paper (FD1/P2) as part of HGF’s in-house tutorial scheme.
Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …Read article
Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder . …Read article
Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …Read article
Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …Read article
Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …Read article
After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …Event details
HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …Event details
HGF is hosting a series of HGF Complete webinars this Spring. Our expert speakers will discuss trade marks and designs in the EU and the UK. We will compare and …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.